top of page

ADDRESSING PERVASIVE TREATMENT CHALLENGES IN DERMATOLOGY

Veradermics has cultivated a dermatology-focused pipeline of five novel product candidates for large-market conditions seen in adults and children that are overdue for new treatment approaches including androgenetic alopecia (pattern hair loss), common warts (verruca vulgaris), molluscum contagiosum, alopecia areata, and atopic dermatitis.

We have a rapidly advancing diverse pipeline of first-in-class candidates

Program Indication

MOA Delivery

PRE-IND

PHASE 1

PHASE 2

PHASE 3

VDPHL

Androgenetic Alopecia

Confidential MOA

Oral

Tablet

VDMN

Common Warts

Candida Antigen Extract​

Immunotherapy​

Dissolvable Microarray

VDAA

Alopecia Areata

Topical
Contact
Immunotherapy

VDAD 

Atopic Dermatitis

Novel

Oral

Immunomodulator

VDMC​
Molluscum Contagiosum

Topical ​

New Chemical Entity​

Antiviral

bottom of page